Ensemble is the first company to successfully and reliably exploit synthetic macrocycle drugs, called Ensemblins™.
With their distinctive macrocyclic ring structure, Ensemblins have unique properties to address difficult-to-address drug targets that are known to play key roles in disease processes, yet are currently undruggable with conventional small molecule drugs. With their unique chemical and biological properties, Ensemblins are a new class of drugs in the emerging therapeutic space between small molecules and biologics.
Ensemble's leadership capabilities in developing macrocycle drugs are based on the company's proprietary, DNA-programmed chemistry drug discovery platform. The company has a pipeline of proprietary and partnered Ensemblin drug candidates to treat a broad range of diseases, including inflammation, oncology and diabetes.
Company Details
- Founded
- -
- Address
- 99 Erie Street, Cambridge,ma 02139,united States
- Phone
- 617-492-6977
- in****@****etx.com
- Industry
- Biotechnology
- Website
- ensembletx.com
- HQ
- Cambridge, MA
- Competitors
- Moderna.
Ensemble Discovery Questions
Ensemble Discovery's helpline number is 617-492-6977
Ensemble Discovery's website is ensembletx.com
Ensemble Discovery's LinkedIn profile is https://www.linkedin.com/company/ensemble-discovery
Ensemble Discovery's industry is
Biotechnology
Ensemble Discovery's top competitors are
Moderna.
Ensemble Discovery's support email address is info@ensembletx.com
Ensemble Discovery's categories are Biotechnology
Ensemble Discovery's founding year is 2004
